In a new policy brief, experts from the Mailman School of Public Health and other institutions highlight the health risks of climate change and opportunities to improve health through decisive action.
The HPV vaccine has great potential to reduce the rate of cervical cancer in Africa, where Columbia researchers are trying to increase vaccination rates with texts.
Mailman experts and other policymakers discuss measures that should be deployed during vaccine rollout to reduce inequities, already worsened by the pandemic, in the U.S. and globally.
Wafaa El-Sadr, MD, MPH, will serve as the next director of Columbia World Projects, an initiative focused on bringing Columbia's academic resources to bear on the great challenges facing humanity.
A treatment that prevents an often-fatal disease in fetuses and newborns only reaches half of the pregnant women around the world who need it, Columbia researchers have found.
The International Collaboration and Exchange Program convenes premedical, medical, and dental students from Columbia University and beyond to discuss their COVID-19 experiences via online coursework.
Writing in NEJM, Wafaa El-Sadr and Jessica Justman urge countries around the world to take concrete steps to assist Africa in staying ahead of the curve, even as they confront their own epidemics.
Researchers hoped treatment of HIV-infected infants within hours of birth would increase remission, but a new study finds that starting treatment within the first two weeks leads to similar outcomes.
ICAP launched the world’s first multi-country HIV treatment program in 2003 and has helped bring life-saving treatment to nearly 1.5 million people in resource-poor regions around the world.
With a new grant from the U.S. President’s Malaria Initiative, Mailman’s ICAP will support the implementation of quality malaria diagnosis and treatment services in Ethiopia.